MedPath

Barre Exercise in Parkinson's

Phase 1
Completed
Conditions
Parkinson Disease
Registration Number
NCT06203990
Lead Sponsor
Washington University School of Medicine
Brief Summary

This study asks if a barre exercise program is a feasible and acceptable form of exercise for individuals with Parkinson disease. The study will also evaluate barre's potential effects on motor outcomes, including balance, strength, and functional mobility.

Detailed Description

The primary objectives of this study are to: 1) evaluate the feasibility and acceptability of a barre exercise intervention and 2) gather preliminary data regarding the effect of a barre exercise intervention on balance, strength, functional mobility and quality of life in individuals with mild to moderate Parkinson disease (PD). Individuals with PD (N=15) will be recruited to participate in a pilot barre exercise class led by a certified barre instructor. The intervention will include 24, 45-50 minute group classes (twice weekly for 12 weeks, excluding holidays). Pre- and post-intervention data collection will include assessments of balance, lower extremity strength, and functional mobility.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • diagnosed by a neurologist with idiopathic Parkinson disease
  • at least 18 years of age
  • a score on the Hoehn & Yahr (H&Y) scale between I-III to indicate mild to moderate disease severity
  • able to provide informed consent
  • able to walk for 10 continuous minutes without assistance from another person
  • stable medication regimen for at least one month prior to enrollment
Exclusion Criteria
  • any neurological condition other than PD
  • history of orthopedic or other medical conditions that limit the ability to safely participate in the intervention or
  • language, visual, or hearing barriers to participation
  • evidence of dementia (Montreal Cognitive Assessment < 24) to ensure understanding of the intervention class instructions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Attendance12 weeks

Number of participants who attended at least 75% of the classes

Retention (Study Completion)12 weeks

Percent of participants who remained enrolled for the duration of the study

Acceptability12 weeks

Mean group rating on the Client Satisfaction Questionnaire, a standardized measure using Likert-scale questions to assess self-reported satisfaction of a program. Range is 1-4, higher scores indicate higher satisfaction

Secondary Outcome Measures
NameTimeMethod
Functional Strength12 weeks

Mean change in time taken to complete five sit to stand movements pre- to post- intervention, measured in seconds. Longer time indicates worse performance.

Gait12 weeks

Mean change in gait speed pre- to post-intervention, measured in meters/second.

Balance12 weeks

Mean change in total score on the Mini Balance Evaluation Systems Test (Mini-BESTest) from pre- to post-intervention. The Mini-BESTest is a brief, clinically relevant assessment of balance, scored on a scale from 0 to 28, with higher scores indicating better balance. A negative change score reflects a decline in balance performance from pre- to post-intervention.

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

Saint Louis, Missouri, United States

Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.